News | August 13, 2023
Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
The medical device sector is considered as one of the sunrise sectors in the country
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
